dc.contributor.author | Quiles-Jiménez, Ana M T | |
dc.contributor.author | Dahl, Tuva Børresdatter | |
dc.contributor.author | Bjørås, Magnar | |
dc.contributor.author | Alseth, Ingrun | |
dc.contributor.author | Halvorsen, Bente | |
dc.contributor.author | Gregersen, Ida | |
dc.date.accessioned | 2023-02-24T12:47:45Z | |
dc.date.available | 2023-02-24T12:47:45Z | |
dc.date.created | 2022-09-01T12:44:59Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Stroke. 2022, 53 (6), 2114-2122. | en_US |
dc.identifier.issn | 0039-2499 | |
dc.identifier.uri | https://hdl.handle.net/11250/3053908 | |
dc.language.iso | eng | en_US |
dc.title | Epitranscriptome in Ischemic Cardiovascular Disease: Potential Target for Therapies | en_US |
dc.title.alternative | Epitranscriptome in Ischemic Cardiovascular Disease: Potential Target for Therapies | en_US |
dc.type | Journal article | en_US |
dc.type | Peer reviewed | en_US |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | This article is not available in NTNU Open due to copyright restrictions | en_US |
dc.source.pagenumber | 2114-2122 | en_US |
dc.source.volume | 53 | en_US |
dc.source.journal | Stroke | en_US |
dc.source.issue | 6 | en_US |
dc.identifier.doi | 10.1161/STROKEAHA.121.037581 | |
dc.identifier.cristin | 2047852 | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 2 | |